Anesthetic considerations in patients with hepatic failure

International Anesthesiology Clinics

Volumn 43, Issue 4, 2005, Pages 45-63

  Garg, Rajeev Kumar ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALCOHOL; ANESTHETIC AGENT; ATRACURIUM; BENZODIAZEPINE DERIVATIVE; CISATRACURIUM; CYANOCOBALAMIN; ESOMEPRAZOLE; ETOMIDATE; HETASTARCH; HISTAMINE; HYDROCODONE; KETAMINE; METHOHEXITAL; MIDAZOLAM; MIVACURIUM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PANCURONIUM; PARACETAMOL; PETHIDINE; REMIFENTANIL; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL;

ADULT; ALCOHOL LIVER CIRRHOSIS; ANESTHESIOLOGICAL TECHNIQUES; CASE REPORT; DENTAL CARIES; DRUG ALCOHOL INTERACTION; DRUG METABOLISM; GASTROESOPHAGEAL REFLUX; HEPATITIS C; HUMAN; LIVER DYSFUNCTION; LIVER FAILURE; LIVER METABOLISM; MALE; NURSING; OUTCOMES RESEARCH; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW;

ANESTHESIA; HUMANS; LIVER FAILURE;

EID: 27544506055     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aia.0000182637.54938.e9     Document Type: Review

References (58)

1. Steadman RH. Anesthesia for liver transplant surgery. Anesthesiol Clin North Am. 2004;22:687-711.
2. Farnsworth N, Fagan SP, Berger DH, et al. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg. 2004;188:580-583.
3. Zein NN. The epidemiology and natural history of hepatitis C virus infection. Cleve Clin J Med. 2003;70(suppl 4):S2-S6.
4. Hunt CM, Washington K. Tetracycline-induced bile duct paucity and prolonged cholestasis. Gastroenterology. 1994;107:1844-1847.
5. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and FELD: application of survival models to liver allocation. Liver Transpl. 2001;7:567-580.
6. Organ Procurement US and Transplantation Network. Annual report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant data 1992-2001. Accessed February 16, 2004.
7. Farrell RL, DeColli JA, Chappelka AR. Significance of abnormal liver function studies in psychiatric admissions to military hospitals. Mil Med. 1975;140:101-103.
8. Blei AT, Larsen FS. Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol. 1999;31:771-776.
9. Cordoba J. Glutamine, myo-inositol, and brain edema in acute liver failure. Hepatology. 1996;23:1291-1292.
10. Ruscito BJ, Harrison NL. Hemoglobin metabolites mimic benzodiazepines and are possible mediators of hepatic encephalopathy. Blood. 2003;102:1525-1528.
11. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med. 1997;337:473-479.
12. Glauser FL. Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantation. Chest. 1990;98:1210-1215.
13. Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology. 1996;23:1067-1072.
14. Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis. 1996;16:379-388.
15. Sheron N, Goka J, Wendon J. Highly elevated levels of plasma cytokines in fulminant hepatic failure. Hepatology. 1990;12:939.
16. Kawasaki T, Takeshita A, Souda K, et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999;94:1918-1922.
17. Krowka MJ, Tajik AJ, Dickson ER, et al. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest. 1990;97:1165-1170.
18. Herve P, Lebrec D, Brenot F, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998;11:1153-1166.
19. Redai I, Emond J, Brentjens T. Anesthetic considerations during liver surgery. Surg Clin North Am. 2004;84:401-411.
20. Castro M, Krowka MJ, Schroeder DR, et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc. 1996;71:543-551.
21. Kuo P. Pulmonary hypertension: considerations in the liver transplant candidate. Transpl Int. 1996;9:141-150.
22. McLaughlin W, Genthner DE, Panella MM, et al. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med. 1999;130:740-743.
23. Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut. 1981;22:585-591.
24. Dagher L, Moore K. The hepatorenal syndrome. Gut. 2001;49:729-737.
25. Roberts LR, Kamath PS. Ascites and hepatorenal syndrome: pathophysiology and management. Mayo Clin Proc. 1996;71:874-881.
26. Moore K, Ward PS, Taylor GW, et al. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology. 1991;100:1069-1077.
27. Moore K, Wendon J, Frazer M, et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 1992;327:1774-1778.
28. Epstein M. Hepatorenal syndrome: emerging perspectives. Semin Nephrol 1997;17:563-575.
29. Cohen JA, Kaplan MM. The SGOT/SGPT ratio-an indicator of alcoholic liver disease. Dig Dis Sci. 1979;24:835-838.
30. Donovan CL, Marcovitz PA, Punch JD, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation. 1996;61:1180-1188.
31. Melendez JA, Arslan V, Fischer ME, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998;187:620-625.
32. Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg. 1998;85:1058-1060.
33. Tegeder I, Lotsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet. 1999;37:17-40.
34. Haberer JP, Schoeffler P, Couderc E, et al. Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth. 1982;54:1267-1270.
35. Navapurkar VU, Archer S, Gupta SK, et al. Metabolism of remifentanil during liver transplantation. Br J Anaesth. 1998;81:881-886.
36. Pandele G, Chaux F, Salvadori C, et al. Thiopental pharmacokinetics in patients with cirrhosis. Anesthesiology. 1983;59:123-126.
37. Duvaldestin P, Chauvin M, Lebrault C, et al. Effect of upper abdominal surgery and cirrhosis upon the pharmacokinetics of methohexital. Acta Anaesthesiol Scand. 1991;35:159-163.
38. van Beem H, Manger FW, van Boxtel C, et al. Etomidate anaesthesia in patients with cirrhosis of the liver: pharmacokinetic data. Anaesthesia. 1983;38(suppl):61-62.
39. Servin F, Cockshott ID, Farinotti R, et al. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth. 1990;65:177-183.
40. MacGilchrist AJ, Birnie GG, Cook A, et al. Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut. 1986;27:190-195.
41. Trouvin JH, Farinotti R, Haberer JP, et al. Pharmacokinetics of midazolam in anaesthetized cirrhotic patients. Br J Anaesth. 1988;60:762-767.
42. Thomas SD, Boyd AH. Prolonged neuromuscular block associated with acute fatty liver of pregnancy and reduced plasma cholinesterase. Eur J Anaesthesiol. 1994;11:245-249.
43. Head-Rapson AG, Devlin JC, Parker CJ, et al. Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis. Br J Anaesth. 1994;73:613-618.
44. Lebrault C, Berger JL, D'Hollander AA, et al. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis. Anesthesiolngy. 1985;62:601-605.
45. Arden JR, Lynam DP, Castagnoli KP, et al. Vecuronium in alcoholic liver disease: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology. 1988;68:771-776.
46. Magorian T, Wood P, Caldwell J, et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg. 1995;80:754-759.
47. Duvaldestin P, Agoston S, Henzel D, et al. Pancuronium pharmacokinetics in patients with liver cirrhosis. Br J Anaesth. 1978;50:1131-1136.
48. Ward S, Neill EA. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). Br J Anaesth. 1983;55:1169-1172.
49. De Wolf AM, Freeman JA, Scott VL, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth. 1996;76:624-628.
50. Hursh D, Gelman S, Bradley EL Jr. Hepatic oxygen supply during halothane or isoflurane anesthesia in guinea pigs. Anesthesiology. 1987;67:701-706.
51. Grundmann U, Zissis A, Bauer C, et al. In vivo effects of halothane, enflurane, and isoflurane on hepatic sinusoidal microcirculation. Acta Anaesthesiol Scand. 1997;41:760-765.
52. Murray JM, Rowlands BJ, Trinick TR. Indocyanine green clearance and hepatic function during and after prolonged anaesthesia: comparison of halothane with isoflurane. Br J Anaesth. 1992;68:168-171.
53. Conzen PF, Vollmar B, Habazettl H, et al. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg. 1992;74:79-88.
54. Holmes MA, Weiskopf RB, Eger EI 2nd, et al. Hepatocellular integrity in swine after prolonged desflurane (1-653) and isoflurane anesthesia: evaluation of plasma alanine aminotransferase activity. Anesth Analg. 1990;71:249-253.
55. Wendon JA, Harrison PM, Keays R, et al. Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure. Hepatology. 1992;15:1067-1071.
56. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247-2256.
57. Hansen E, Wolff N, Knuechel R, et al. Tumor cells in blood shed from the surgical field. Arch Surg. 1995;130:387-393.
58. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33:721-726.